Speaking at BIO2025, rare disease leaders from Ultragenyx, Amylyx and Yale questioned the need for the new regulatory pathway ...

U.S. Senator Bill Cassidy, chair of the U.S. Senate Committee on Health, Education, Labor and Pensions called for U.S.

NRx Pharmaceuticals (NASDAQ: NRXP) has filed for the newly launched FDA Commissioner's National Priority Voucher (CNPV) program, seeking accelerated ...

Curay, the FDA’s acting top drug regulator, is stepping down from her post after serving at the agency for more than eight ...

The U.S. Food and Drug Administration (FDA) has initiated an immediate review of clinical trials involving the international ...

And more health news stories you need to start your week.

Novo Nordisk is halting its collaboration with Hims & Hers Health over the sale of weight loss drugs, STAT says. The ...

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, ...

The U.S. Food and Drug Administration (FDA) has unveiled the Commissioner’s National Priority Voucher (CNPV) program, aiming ...

But current and former agency staff, as well as medical ethics experts, say recent cuts at the FDA are already making it more ...

US market for illegal, flavoured e-cigarettes from China supplied by middlemen lying in plain sight. Read more at ...